Skip to main content
. 2011 Nov 10;11:305. doi: 10.1186/1472-6963-11-305

Table 2.

Utilization of healthcare among patients with metastatic lung cancer receiving chemotherapy

Value
n = 4068
Inpatient, mean
 Acute hospital
  Admissions (#) 1.5
  Days (#) 8.9
Outpatient Services, mean
 Physician Office (#) 41.5
 Emergency Room (#) 1.6
 Hospital Outpatient (#) 18.2
 Home Health (#) 4.7
 Other (#) 10.1
Pharmacy Prescriptions (#), mean 39.7
Inpatient, n (%)
 Acute hospital 2,933 (72.1%)
Outpatient Services*, n (%)
 Emergency Room 2,532 (62.2%)
 Physician Office/Hospital Outpatient
  Evaluation and Management 3,947 (97.0%)
  Laboratory 3,331 (81.9%)
  Radiology Diagnostic 3,691 (90.7%)
  Radiology Therapeutic 2,241 (55.1%)
  Nuclear Medicine 1,826 (44.9%)
  Anesthesia and invasive procedures 2,581 (63.4%)
  Blood & Transfusion 338 (8.3%)
  Physical & Occupational Therapy 402 (9.9%)
  Medical & Surgical Supplies 2,104 (51.7%)
  Mental health-care 2,772 (68.1%)
  Other 134 (3.3%)
  Chemo administration 3,943 (96.9%)
  Subtotal 4,032 (99.1%)
 Home Health/Hospice/Skilled Nursing 2,200 (54.1%)
 Other 3,314 (81.5%)
 Total 4,053 (99.6%)
Medication, n (%)
 Chemotherapy 4,068 (100.0%)
 G-CSF 1,159 (28.5%)
 ESAs 1,859 (45.7%)
 Pain, sedatives, antidepressants 3,629 (89.2%)
 Anti-infectives 2,991 (73.5%)
 Anti-emetics 3,445 (84.7%)
 Bisphosphonates 721 (17.7%)
 Biologics 186 (4.6%)
 Gastrointestinal 2,337 (57.4%)
 Electrolytes, Caloric, Water 1,981 (48.7%)
 Cardiovascular 2,161 (53.1%)
 Blood products & Anticoagulants 1,393 (34.2%)
 Other 3,976 (97.7%)
  Total 4,068 (100.0%)
TOTAL 4,068 (100.0%)

*Other than medication administration